Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening

Matteo Boretto, Nina Maenhoudt, Xinlong Luo, Aurélie Hennes, Bram Boeckx, Bich Ngoc Bui, Ruben Heremans, Lisa Perneel, Hiroto Kobayashi, Indra Van Zundert, Hilde Brems, Benoit Cox, Marc Ferrante, Hiroshi Uji‐i, Kian Peng Koh, Thomas M. D’Hooghe, Arne Vanhie, Ignace B. Vergote, Christel Meuleman, Carla Tomassetti, Diether Lambrechts, Joris Vriens, Dirk Timmerman, Hugo E J Vankelecom

View at source ↗Article507 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1038/s41556-019-0360-z
Published
Aug 1, 2019
Venue
Nature Cell Biology
DOI
10.1038/s41556-019-0360-z
PubMed
31371824
Categories
Cancer Cells and Metastasis
License
other-oa
Provenance
openalex

Topics